Dimensional Fund Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Dimensional Fund Advisors’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,595	Closed	-$89K	–	3295
2016 Q2	$89K	Hold	3,595	–	–	﹤0.01%	3241
2016 Q1	$104K	Hold	3,595	–	–	﹤0.01%	3233
2015 Q4	$133K	Sell	3,595 -1,283	-26%	-$56.6K	﹤0.01%	3249
2015 Q3	$238K	Sell	4,878 -5,492	-53%	-$384K	﹤0.01%	3224
2015 Q2	$715K	Buy	+10,370	New	+$480K	﹤0.01%	3081
2014 Q3	–	Sell	-435	Closed	-$12K	–	3576
2014 Q2	$12K	Hold	435	–	–	﹤0.01%	3527
2014 Q1	$12K	Hold	435	–	–	﹤0.01%	3533
2013 Q4	$11K	Hold	435	–	–	﹤0.01%	3497
2013 Q3	$14K	Buy	+435	New	+$13.5K	﹤0.01%	3515

Other funds holding ANTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's ANTH Position: Q3 2016 in Review

Dimensional Fund Advisors sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2016, closing a stake of 3,595 shares — an estimated $89K sold.

Dimensional Fund Advisors first reported a position in ANTH in Q3 2013 and held it in 9 quarters. The position peaked at $715K in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q3 2016.

Dimensional Fund Advisors reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
Dimensional Fund Advisors sold 3,595 Anthera Pharmaceuticals, Inc. shares in Q3 2016, an estimated $89K.
Dimensional Fund Advisors first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2013 and held it in 9 quarters.
Dimensional Fund Advisors's Anthera Pharmaceuticals, Inc. position peaked at $715K in Q2 2015.
72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2016.

Based on Dimensional Fund Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.